Reach Us +1-218-451-2974


Brain Resilience And Plasticity In The Face Of Alzheimer?s Disease | 12487
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Brain resilience and plasticity in the face of Alzheimer?s disease

International Conference on Psychology, Autism and Alzheimers Disease

Ira Driscoll

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.002

Alzheimer?s disease (AD), an age-related neurodegenerative disorder and the most common cause of dementia, represents the culmination of neuropathological changes thought to evolve over several decades. Recent findings from prospective longitudinal studies with autopsy component suggest that neuritic plaques and neurofibrillary tangles, the neuropathological hallmarks of AD, are not limited to individuals with dementia. These ?hallmark? pathologic changes can also be present in the brains of clinically normal older adults - a condition we defined as Asymptomatic AD (ASYMAD). I will review the historical background and highlight the combined clinical, pathologic and morphometric evidence related to ASYMAD from the Baltimore Longitudinal Study of Aging (BLSA). The BLSA was established in 1958, supported since by the National Institute on Aging (NIA) intramural research program, with an autopsy program in place since 1986 in combination with comprehensive neurologic and cognitive evaluations. Although it remains unclear whether ASYMAD individuals would remain clinically normal with longer survival, our findings suggest that they seem to be able to compensate for or delay the appearance of clinical symptoms well into old age. Understanding the nature of changes during this apparently asymptomatic state may shed light on the mechanisms that forestall the progression of the disease and allow for maintenance of cognitive health, an important area of research that has been understudied relative to the identification of risks and pathways to negative health outcomes.
Ira Driscoll has received her Ph.D. in Neuroscience from the Canadian Centre for Behavioural Neuroscience at the University of Lethbridge in Canada and completed postdoctoral studies at the National Institute on Aging/NIH in Baltimore, MD. She is currently an Assistant Professor at the University of Wisconsin-Milwaukee.